HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice.

Abstract
Honokiol, a constituent of Magnolia obovata, has various pharmacological effects, including protection against cerebral ischemia. However, few studies have been conducted to evaluate the possible neuroprotective effects of honokiol against cerebral ischemia. We recently reported that cerebral ischemic neuronal damage could be triggered by glucose intolerance that develops after the onset of ischemic stress (i.e., post-ischemic glucose intolerance). In addition, suppression of post-ischemic glucose intolerance significantly ameliorated ischemic neuronal damage. Here, we investigated the effects of honokiol on the development of post-ischemic glucose intolerance and neuronal damage. Mice were subjected to middle cerebral artery occlusion (MCAO) for 2 h. The development of post-ischemic glucose intolerance on day 1 and neuronal damage on day 3 after MCAO were significantly reduced by intraperitoneal administration of honokiol (10 mg/kg) compared with the vehicle-treated group. Honokiol did not affect serum insulin or adiponectin levels. However, honokiol significantly decreased the expression of phosphoenolpyruvate carboxykinase and increased the expression of 5'-AMP-activated protein kinase (AMPK) on day 1 after MCAO, compared with the vehicle-treated MCAO group. The results of this study suggest that honokiol could prevent post-ischemic glucose intolerance in an AMPK-dependent manner, which may be involved in the neuroprotective effects of honokiol against cerebral ischemia.
AuthorsShinichi Harada, Maya Kishimoto, Mana Kobayashi, Kazuo Nakamoto, Wakako Fujita-Hamabe, Hwei-Hsien Chen, Ming-Huan Chan, Shogo Tokuyama
JournalJournal of natural medicines (J Nat Med) Vol. 66 Issue 4 Pg. 591-9 (Oct 2012) ISSN: 1861-0293 [Electronic] Japan
PMID22261858 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Retracted Publication)
Chemical References
  • Adiponectin
  • Biphenyl Compounds
  • Insulin
  • Lignans
  • honokiol
  • AMP-Activated Protein Kinases
  • Phosphoenolpyruvate Carboxykinase (ATP)
Topics
  • AMP-Activated Protein Kinases (metabolism)
  • Adiponectin (blood)
  • Animals
  • Biphenyl Compounds (therapeutic use)
  • Brain Ischemia (blood, drug therapy)
  • Glucose Intolerance (blood, drug therapy)
  • Infarction, Middle Cerebral Artery
  • Insulin (blood)
  • Lignans (therapeutic use)
  • Male
  • Mice
  • Phosphoenolpyruvate Carboxykinase (ATP) (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: